Mesoblast Statistics
NASDAQ: MESOHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
13.94+0.33 (+2.42%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Mesoblast by the numbers
Mesoblast has a market capitalization of $1.81 billion based on 129.85M shares outstanding. With trailing EPS of $-0.44, Mesoblast is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 11.5% below its 50-day average and 12.3% below its 200-day average.
Average daily trading volume is 236.60K shares, or about $3.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
MESO valuation vs. peer median
| Metric | MESO | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.81B | $1.90B | -5% |
| Forward P/E | 30.6 | 25.6 | +20% |
| Avg. volume | 236.60K | 1.46M | -84% |
Peer median across 8 companies: NVAX, VIR, VCEL, ALVO, IMCR, BCRX, MAZE, TSHA.
Valuation
- Market cap
- $1.81B
- Forward P/E
- 30.64
- EPS (TTM)
- $-0.44
- Shares outstanding
- 129.85M
Price and trading
- Previous close
- 13.61
- Open
- 13.71
- Day range
- 13.71 – 14.10
- 52-week range
- 13.05 – 21.50
- 52-week change
- -22.94%
- Beta
- —
- Volume
- 240.62K
- Average volume
- 236.60K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 26, 2026
Additional statistics
- Market Cap
- 1.81B
- Forward Pe
- 30.64
- Eps
- -0.44
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 21.50
- Week52 Low
- 13.05
- Avg Volume
- 236.60K
- Shares Outstanding
- 129.85M
- Ma50
- 15.75
- Ma200
- 15.90
- Earnings Date
- Aug 26, 2026
- Pct From52w High
- -35.16%
- Pct From52w Low
- 6.82%